Navigation Links
NCPA Announces Kathleen Jaeger as CEO

ALEXANDRIA, Va., Oct. 24 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) today announced the appointment of Kathleen Jaeger as Executive Vice President and CEO, heralding her as an ideal choice to build on the association's recent accomplishments and lead it to new heights as an advocate for, and supporter of, independent community pharmacies and the patients they serve.



NCPA President and Arlington, TX pharmacy owner Joseph H. Harmison, PD, made the announcement during his address to NCPA's 112th Annual Convention and Trade Exposition.

"Kathleen brings to NCPA a demonstrated track record of successful advocacy along with a first-hand pharmacy background," Harmison said. "Kathleen's knowledge of the pharmacy industry and proven Washington expertise make her a perfect fit for NCPA."

"Kathleen has the experience, vision and leadership capabilities to take this well-positioned association and guide it to an even brighter future to better serve community pharmacists and their patients," added Lonny D. Wilson, D.Ph., Chairman of NCPA's Executive Committee and CEO of Pharmacy Providers of Oklahoma.

"I am absolutely honored to join NCPA and represent independent community pharmacists and the patients we care for each day," Jaeger said. "As the daughter of an independent community pharmacist, and as a pharmacist myself, I understand the critical and growing role neighborhood pharmacies play in our healthcare system as well as the challenges they face.

"Every day, millions of Americans depend on community pharmacists for quality medicines and expert counseling to feel better and lead more productive lives," Jaeger added.  "Community pharmacies not only effectively and efficiently deliver this critical care to consumers, they do so while also substantially reducing overall health care costs. Thus, we need to ensure that independent community pharmacists are indispensible to America's health care system today, tomorrow and beyond."

From 2002-2010, Jaeger served as President and CEO of the Generic Pharmaceutical Association (GPhA).  Jaeger is credited with transforming the association into a powerful voice for the generic industry, developing aggressive and effective public policy, advocacy and communications programs that resulted in numerous legislative and regulatory victories.

Prior to leading GPhA, Jaeger chaired the Food and Drug Practice for the McKenna and Cuneo law firm and, later, Kirkpatrick and Lockhart. She earned a Juris Doctor from Catholic University and a BS in Pharmacy from the University of Rhode Island. Her appointment is effective Nov. 1, 2010.  

The National Community Pharmacists Association (NCPA®) represents America's community pharmacists, including the owners of more than 22,700 independent community pharmacies, pharmacy franchises, and chains. Together they represent an $88 billion health-care marketplace, employ over 65,000 pharmacists, and dispense over 40% of all retail prescriptions. To learn more go to or read NCPA's blog, The Dose, at

SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/27/2017)... CAESAREA, Israel and NEW YORK , Sept. ... company with mobile health and big data solutions, today announced that its ... today. Please check your local TV listings for when The Dr. Oz ... ... ninth season this month. ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):